EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Glenn E. Palomaki, Monica R. McClain, Stephanie Melillo, Heather L. Hampel, Stephen N Thibodeau

Research output: Contribution to journalArticle

318 Citations (Scopus)

Abstract

Funding for this study was provided by the National Office of Public Health Genomics, Centers for Disease Control and Prevention, through a contract (200-2003-01396-0128) with McK- ing Consulting Corporation, Inc. We thank the members of the Technical Evaluation Panel, including EGAPP Working Group members Celia I. Kaye, MD, University of Colorado at Denver and Health Sciences Center; Margaret Piper, PhD, MPH, Blue Cross/Blue Shield Association Technology Evaluation Center; James E. Haddow, MD, Women and Infants Hospital, The Warren Alpert School of Medicine at Brown University; Sue Richards, PhD, Oregon Health and Science University; and Linda A. Bradley, PhD, National Office of Public Health Genomics, CDC, who provided guidance and comments on drafts of this manuscript. We also thank Scott D. Grosse, PhD, National Center on Birth Defects and Developmental Disabilities, CDC and Mercy Mvundura, PhD, National Office of Public Health Genomics, CDC, for their helpful comments regarding the economic analyses.

Original languageEnglish (US)
Pages (from-to)42-65
Number of pages24
JournalGenetics in Medicine
Volume11
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Centers for Disease Control and Prevention (U.S.)
Genomics
Blue Cross Blue Shield Insurance Plans
Morbidity
Mortality
Public Health
DNA
Piper
Developmental Disabilities
Health
Contracts
Economics
Medicine
Technology

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

EGAPP supplementary evidence review : DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. / Palomaki, Glenn E.; McClain, Monica R.; Melillo, Stephanie; Hampel, Heather L.; Thibodeau, Stephen N.

In: Genetics in Medicine, Vol. 11, No. 1, 01.2009, p. 42-65.

Research output: Contribution to journalArticle

Palomaki, Glenn E. ; McClain, Monica R. ; Melillo, Stephanie ; Hampel, Heather L. ; Thibodeau, Stephen N. / EGAPP supplementary evidence review : DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. In: Genetics in Medicine. 2009 ; Vol. 11, No. 1. pp. 42-65.
@article{e587bee36d0d4919a80c4e1558171dd4,
title = "EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome",
abstract = "Funding for this study was provided by the National Office of Public Health Genomics, Centers for Disease Control and Prevention, through a contract (200-2003-01396-0128) with McK- ing Consulting Corporation, Inc. We thank the members of the Technical Evaluation Panel, including EGAPP Working Group members Celia I. Kaye, MD, University of Colorado at Denver and Health Sciences Center; Margaret Piper, PhD, MPH, Blue Cross/Blue Shield Association Technology Evaluation Center; James E. Haddow, MD, Women and Infants Hospital, The Warren Alpert School of Medicine at Brown University; Sue Richards, PhD, Oregon Health and Science University; and Linda A. Bradley, PhD, National Office of Public Health Genomics, CDC, who provided guidance and comments on drafts of this manuscript. We also thank Scott D. Grosse, PhD, National Center on Birth Defects and Developmental Disabilities, CDC and Mercy Mvundura, PhD, National Office of Public Health Genomics, CDC, for their helpful comments regarding the economic analyses.",
author = "Palomaki, {Glenn E.} and McClain, {Monica R.} and Stephanie Melillo and Hampel, {Heather L.} and Thibodeau, {Stephen N}",
year = "2009",
month = "1",
doi = "10.1097/GIM.0b013e31818fa2db",
language = "English (US)",
volume = "11",
pages = "42--65",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - EGAPP supplementary evidence review

T2 - DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

AU - Palomaki, Glenn E.

AU - McClain, Monica R.

AU - Melillo, Stephanie

AU - Hampel, Heather L.

AU - Thibodeau, Stephen N

PY - 2009/1

Y1 - 2009/1

N2 - Funding for this study was provided by the National Office of Public Health Genomics, Centers for Disease Control and Prevention, through a contract (200-2003-01396-0128) with McK- ing Consulting Corporation, Inc. We thank the members of the Technical Evaluation Panel, including EGAPP Working Group members Celia I. Kaye, MD, University of Colorado at Denver and Health Sciences Center; Margaret Piper, PhD, MPH, Blue Cross/Blue Shield Association Technology Evaluation Center; James E. Haddow, MD, Women and Infants Hospital, The Warren Alpert School of Medicine at Brown University; Sue Richards, PhD, Oregon Health and Science University; and Linda A. Bradley, PhD, National Office of Public Health Genomics, CDC, who provided guidance and comments on drafts of this manuscript. We also thank Scott D. Grosse, PhD, National Center on Birth Defects and Developmental Disabilities, CDC and Mercy Mvundura, PhD, National Office of Public Health Genomics, CDC, for their helpful comments regarding the economic analyses.

AB - Funding for this study was provided by the National Office of Public Health Genomics, Centers for Disease Control and Prevention, through a contract (200-2003-01396-0128) with McK- ing Consulting Corporation, Inc. We thank the members of the Technical Evaluation Panel, including EGAPP Working Group members Celia I. Kaye, MD, University of Colorado at Denver and Health Sciences Center; Margaret Piper, PhD, MPH, Blue Cross/Blue Shield Association Technology Evaluation Center; James E. Haddow, MD, Women and Infants Hospital, The Warren Alpert School of Medicine at Brown University; Sue Richards, PhD, Oregon Health and Science University; and Linda A. Bradley, PhD, National Office of Public Health Genomics, CDC, who provided guidance and comments on drafts of this manuscript. We also thank Scott D. Grosse, PhD, National Center on Birth Defects and Developmental Disabilities, CDC and Mercy Mvundura, PhD, National Office of Public Health Genomics, CDC, for their helpful comments regarding the economic analyses.

UR - http://www.scopus.com/inward/record.url?scp=59849129653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849129653&partnerID=8YFLogxK

U2 - 10.1097/GIM.0b013e31818fa2db

DO - 10.1097/GIM.0b013e31818fa2db

M3 - Article

C2 - 19125127

AN - SCOPUS:59849129653

VL - 11

SP - 42

EP - 65

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 1

ER -